Lifeline Biotechnologies, Inc. engages in the development and marketing of technology, applications, and medical devices. The company is headquartered in Reno, Nevada. The company went IPO on 2001-06-21. The firm was founded in 1981.
根据最新的财务报表(Form-10K),Infrax Systems Inc 的总资产为 $0,净亏损为 $0
LLBO 的关键财务比率是什么?
Infrax Systems Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Lifeline Biotechnologies Inc 的收入按细分市场或地理位置如何划分?
Infrax Systems Inc 最大收入来源是 Fiber Optic Management Software System,在最近的收益报告中收入为 1,650,000。就地区而言, United States 是 Infrax Systems Inc 的主要市场,收入为 1,650,000。